journal article·2024-04Open access

Injectable MSC Spheroid and Microgel Granular Composites for Engineering Tissue

Nikolas Di Caprio, Matthew D. Davidson, Andrew C. Daly, Jason A. Burdick

Advanced Materials· Volume 36· Issue 14

Abstract

Abstract Many cell types require direct cell–cell interactions for differentiation and function; yet, this can be challenging to incorporate into 3‐dimensional (3D) structures for the engineering of tissues. Here, a new approach is introduced that combines aggregates of cells (spheroids) with similarly‐sized hydrogel particles (microgels) to form granular composites that are injectable, undergo interparticle crosslinking via light for initial stabilization, permit cell–cell contacts for cell signaling, and allow spheroid fusion and growth. One area where this is important is in cartilage tissue engineering, as cell–cell contacts are crucial to chondrogenesis and are missing in many tissue engineering approaches. To address this, granular composites are developed from adult porcine mesenchymal stromal cell (MSC) spheroids and hyaluronic acid microgels and simulations and experimental analyses are used to establish the importance of initial MSC spheroid to microgel volume ratios to balance mechanical support with tissue growth. Long‐term chondrogenic cultures of granular composites produce engineered cartilage tissue with extensive matrix deposition and mechanical properties within the range of cartilage, as well as integration with native tissue. Altogether, a new strategy of injectable granular composites is developed that leverages the benefits of cell–cell interactions through spheroids with the mechanical stabilization afforded with engineered hydrogels.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering University of Pennsylvania Philadelphia PA 19104 USA

BioFrontiers Institute University of Colorado Boulder Boulder CO 80303 USA

Department of Chemical and Biological Engineering University of Colorado Boulder Boulder CO 80303 USA

Biomedical Engineering University of Galway Galway H91 TK33 Ireland

CURAM SFI Research Centre for Medical Devices University of Galway Galway H91 W2TY Ireland

Funding

National Institutes of Health · National Science Foundation

References (72)

Show source-provided references
1. 10.1053/joca.1999.030610.1053/joca.1999.0306 ↗
2. 10.1038/s41586-020-2797-410.1038/s41586-020-2797-4 ↗
3. 10.1002/adhm.20210233710.1002/adhm.202102337 ↗
4. 10.1007/s00441-014-1830-z10.1007/s00441-014-1830-z ↗
5. 10.1016/j.actbio.2022.09.05210.1016/j.actbio.2022.09.052 ↗
6. 10.1007/s00167-015-3822-210.1007/s00167-015-3822-2 ↗
7. 10.1016/j.joca.2005.09.00210.1016/j.joca.2005.09.002 ↗
8. 10.1016/j.actbio.2017.12.03810.1016/j.actbio.2017.12.038 ↗
9. 10.1002/adbi.20190014110.1002/adbi.201900141 ↗
10. 10.1016/j.jmbbm.2018.04.02610.1016/j.jmbbm.2018.04.026 ↗
11. 10.1016/j.ijbiomac.2018.01.04610.1016/j.ijbiomac.2018.01.046 ↗
12. 10.1007/s10439-018-2028-410.1007/s10439-018-2028-4 ↗
13. 10.1016/j.biomaterials.2011.07.05610.1016/j.biomaterials.2011.07.056 ↗
14. 10.1016/j.actbio.2017.10.00710.1016/j.actbio.2017.10.007 ↗
15. 10.1016/j.biomaterials.2020.12060710.1016/j.biomaterials.2020.120607 ↗
16. 10.1016/j.actbio.2022.01.04710.1016/j.actbio.2022.01.047 ↗
17. 10.1002/adhm.20210104810.1002/adhm.202101048 ↗
18. 10.1088/1758-5090/ac36be10.1088/1758-5090/ac36be ↗
19. 10.1016/j.biomaterials.2018.12.02810.1016/j.biomaterials.2018.12.028 ↗
20. 10.1002/advs.20210332010.1002/advs.202103320 ↗
21. 10.1088/1758-5090/aa9ef110.1088/1758-5090/aa9ef1 ↗
22. 10.1088/1758-5090/abc39c10.1088/1758-5090/abc39c ↗
23. 10.4081/ejh.2013.e3110.4081/ejh.2013.e31 ↗
24. 10.1073/pnas.132405011110.1073/pnas.1324050111 ↗
25. 10.1002/adhm.20170119910.1002/adhm.201701199 ↗
26. 10.1126/sciadv.aaw511110.1126/sciadv.aaw5111 ↗
27. 10.1016/j.actbio.2019.02.05410.1016/j.actbio.2019.02.054 ↗
28. 10.1038/nmat429410.1038/nmat4294 ↗
29. 10.1021/acsbiomaterials.6b0044410.1021/acsbiomaterials.6b00444 ↗
30. 10.1039/C9BM01524H10.1039/C9BM01524H ↗
31. 10.1016/j.actbio.2018.07.01510.1016/j.actbio.2018.07.015 ↗
32. 10.1002/macp.20130002310.1002/macp.201300023 ↗
33. 10.1016/j.actbio.2023.03.04510.1016/j.actbio.2023.03.045 ↗
34. 10.1002/adma.20210919410.1002/adma.202109194 ↗
35. 10.1002/smll.20220111510.1002/smll.202201115 ↗
36. 10.1039/D0SM00517G10.1039/D0SM00517G ↗
37. Xu K. L. · bioRxiv Prepr. · 2023
38. 10.1126/sciadv.aaw245910.1126/sciadv.aaw2459 ↗
39. United States Bone and Joint Initiative: The Burden of Musculoskeletal Diseases in the United States 4th Edition 2020.
40. 10.1002/acr.2241210.1002/acr.22412 ↗
41. 10.1177/036354651880801210.1177/0363546518808012 ↗
42. 10.18063/ijb.77510.18063/ijb.775 ↗
43. 10.1073/pnas.121410011010.1073/pnas.1214100110 ↗
44. 10.1002/adhm.20170119910.1002/adhm.201701199 ↗
45. 10.1016/j.actbio.2019.03.04610.1016/j.actbio.2019.03.046 ↗
46. 10.1016/j.biomaterials.2022.12140510.1016/j.biomaterials.2022.121405 ↗
47. 10.1088/1758-5090/ac3acb10.1088/1758-5090/ac3acb ↗
48. 10.1016/j.actbio.2012.04.03310.1016/j.actbio.2012.04.033 ↗
49. 10.1002/adhm.20230017410.1002/adhm.202300174 ↗
50. Pereira T. V. · BMJ · 2022 · 37810.1136/bmj-2022-069722 ↗
51. 10.1186/s12967-016-0998-210.1186/s12967-016-0998-2 ↗
52. 10.3389/fvets.2019.0019210.3389/fvets.2019.00192 ↗
53. 10.1016/j.cobme.2020.01.00510.1016/j.cobme.2020.01.005 ↗
54. 10.1038/s41563-022-01400-410.1038/s41563-022-01400-4 ↗
55. 10.1146/annurev.bioeng.4.110701.12030910.1146/annurev.bioeng.4.110701.120309 ↗
56. 10.1007/s00429005029110.1007/s004290050291 ↗
57. 10.1136/ard.2004.02240010.1136/ard.2004.022400 ↗
58. 10.1016/j.joca.2018.08.01310.1016/j.joca.2018.08.013 ↗
59. 10.1088/1748-6041/7/2/02411010.1088/1748-6041/7/2/024110 ↗
60. 10.1002/adhm.20140069510.1002/adhm.201400695 ↗
61. 10.1002/adfm.20200592910.1002/adfm.202005929 ↗
62. 10.1021/ma201624810.1021/ma2016248 ↗
63. 10.1002/adma.20160226810.1002/adma.201602268 ↗
64. 10.1073/pnas.161177111410.1073/pnas.1611771114 ↗
65. 10.1016/j.actbio.2021.03.00310.1016/j.actbio.2021.03.003 ↗
66. 10.1002/adhm.20180132610.1002/adhm.201801326 ↗
67. 10.1021/acsami.7b0072810.1021/acsami.7b00728 ↗
68. 10.1016/j.joca.2009.07.00310.1016/j.joca.2009.07.003 ↗
69. 10.1016/j.jmbbm.2012.03.00610.1016/j.jmbbm.2012.03.006 ↗
70. 10.1002/adbi.20190028610.1002/adbi.201900286 ↗
71. 10.1111/j.1365-2818.2006.01706.x10.1111/j.1365-2818.2006.01706.x ↗
72. 10.1002/advs.20220611710.1002/advs.202206117 ↗